Henney Defends User Fees As Essential To Improving PMA Review Times
This article was originally published in The Gray Sheet
Executive Summary
FDA review of medical device premarket approval applications is "ripe" for the implementation of user fees, FDA Commissioner Jane Henney said at the Feb. 23 House Appropriations/Agriculture Subcommittee hearing on the agency's fiscal year 2000 budget request.